Business Description
Alligator Bioscience AB
ISIN : SE0000767188
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.8 | |||||
Equity-to-Asset | -0.83 | |||||
Debt-to-Equity | -0.13 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -27.62 | |||||
Beneish M-Score | -3.54 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 52 | |||||
3-Year EBITDA Growth Rate | 22 | |||||
3-Year EPS without NRI Growth Rate | 23.3 | |||||
3-Year FCF Growth Rate | 29.1 | |||||
3-Year Book Growth Rate | -72.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 52.11 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.09 | |||||
9-Day RSI | 45.68 | |||||
14-Day RSI | 41.88 | |||||
6-1 Month Momentum % | -78.24 | |||||
12-1 Month Momentum % | -64.52 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.35 | |||||
Quick Ratio | 0.35 | |||||
Cash Ratio | 0.29 | |||||
Days Sales Outstanding | 42.31 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -69.9 | |||||
Shareholder Yield % | -46.19 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -865.46 | |||||
Net Margin % | -895.57 | |||||
FCF Margin % | -838.57 | |||||
ROA % | -206.01 | |||||
ROIC % | -159.52 | |||||
ROC (Joel Greenblatt) % | -1318.19 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.01 | |||||
EV-to-EBIT | -0.65 | |||||
EV-to-EBITDA | -0.68 | |||||
EV-to-Revenue | 5.59 | |||||
EV-to-FCF | -0.67 | |||||
Earnings Yield (Greenblatt) % | -154.3 | |||||
FCF Yield % | -121.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Alligator Bioscience AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 2.463 | ||
EPS (TTM) (€) | -0.032 | ||
Beta | 1.62 | ||
Volatility % | 137.26 | ||
14-Day RSI | 41.88 | ||
14-Day ATR (€) | 0.004318 | ||
20-Day SMA (€) | 0.01846 | ||
12-1 Month Momentum % | -64.52 | ||
52-Week Range (€) | 0.013 - 0.1316 | ||
Shares Outstanding (Mil) | 759.71 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Alligator Bioscience AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Alligator Bioscience AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Alligator Bioscience AB Frequently Asked Questions
What is Alligator Bioscience AB(FRA:7AL)'s stock price today?
When is next earnings date of Alligator Bioscience AB(FRA:7AL)?
Does Alligator Bioscience AB(FRA:7AL) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |